In a strategic move that underscores its confidence in the healthcare sector, Dubai Investments PJSC has announced the acquisition of an additional 80% stake in Clemenceau Medical Center Dubai (CMC Dubai), bringing its total ownership to 100%. This development is a significant milestone in Dubai Investments' strategy of increasing its stake in high-quality businesses with strong long-term growth prospects.

Located in Dubai Healthcare City, CMC Dubai is recognized as one of the leading tertiary care hospitals in the UAE. It is renowned for its advanced healthcare services, delivered by internationally trained physicians using state-of-the-art medical technologies. Since its inception in 2020, CMC Dubai has built a reputation for clinical excellence, offering specialized treatment capabilities and handling complex medical procedures. The hospital caters to a growing patient base from the UAE, GCC, and international markets.

Currently, CMC Dubai operates more than 100 inpatient beds, supported by a multidisciplinary team of healthcare professionals. The hospital's continued growth in patient volumes and expansion of specialized services have strengthened its institutional reputation, reinforcing its position as a key healthcare provider within the UAE's healthcare ecosystem.

Commenting on the acquisition, Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, stated, 'The 100% ownership of Clemenceau Medical Center Dubai reflects the Group’s conviction in the long-term growth potential of the healthcare sector and the strategy of increasing ownership in high-quality businesses where the Group can create greater value through active stewardship and long-term investment.'

With full ownership, Dubai Investments gains enhanced strategic and operational flexibility, enabling the Group to support CMC Dubai's expansion, strengthen its specialized healthcare offerings, and fully benefit from future growth. The Group plans to continue investing in capabilities that enhance patient outcomes, operational excellence, and long-term competitiveness, further reinforcing CMC Dubai's position within the UAE's healthcare ecosystem while creating sustainable value for shareholders.

As part of the internationally recognized Clemenceau Medicine network, CMC Dubai combines global medical expertise with world-class healthcare infrastructure to deliver comprehensive inpatient and outpatient services across a broad range of medical specialties. Supported by advanced diagnostic technologies and modern healthcare facilities, the hospital continues to expand its capabilities and strengthen its position as a destination for high-quality healthcare in the region.

Given the strategic acquisition and the promising growth prospects of the healthcare sector, investors might consider a 'buy' recommendation for Dubai Investments PJSC. The company's strategic focus on high-growth sectors and its robust portfolio diversification make it an attractive option for long-term investment.